Hop-on Returns One Billion Common Shares to

New Post Public Reply Private Reply Replies (1) Message Board
huskerguy
Hop-on Returns One Billion Common Shares to Treasury

7:16 AM ET 5/1/14 | Marketwire
Hop-on, Inc. (OTC Pink: HPNN) (PINKSHEETS: HPNN) is pleased to announce that today it has returned one billion (1,000,000,000) shares to treasury. These shares were held in escrow in anticipation of conversion of debt by the Company's long term debt holders, and these debt holders have elected to take, under their Debt Exchange Agreements, preferred stock of the Company, thereby allowing Hop-on to return these shares to treasury.

In conjunction with the press release yesterday, this means there will be no dilution of Hop-on shareholders from debt conversions for over a year and a positive $7.1 million paid in capital on the balance sheet.

Announced previously, the Debt Exchange Agreements removed $7,162,000 in debt from Hop-on's balance sheet. Not only was the long term debt removed from the balance sheet, but the conversion to preferred equity provided a boost to the stockholders' equity portion of the balance sheet, and this amount is now booked as additional paid in capital. This positive financial move will be reflected in the next financial statement filed by the Company.

Peter Michaels, Hop-on CEO, stated, "As promised, Hop-on is not diluting the current shareholders. In fact, with this staggering number of shares having been returned to treasury, we have compressed the shares outstanding even more. This is positive for current and future shareholders, as the value of their investment should not be diluted, adding value to their commitment to Hop-on. At the upcoming shareholders' meeting, we look forward to discussing upcoming potential mergers, our goals to become a fully reporting public company, getting off of pink sheets, and enhancing shareholder value even more as the year progresses."

About Hop-on, Inc. Hop-on, Inc. is a global ODM and OEM manufacturer of electronics, based in the United States. Over the past 20 years, Hop-on has successfully secured essential patents for mobile communications and computing technologies, and is respected for developing the world's first disposable cell phone. Hop-on's focus on smartphones and innovative mobile device applications is bringing cost friendly solutions to today's demanding world market. Hop-on is also diversified in nutraceutical and cannabinoid technologies through its subsidiary Re-Medical, Inc. For more information, please visit www.hop-on.com and www.re-medical.com

Hop-On Inc (HPNN) Stock Research Links

HPNN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading